Associations of genetically determined iron status across the phenome: A mendelian randomization study
Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The objective of this study was to explore the broad clinical effects of varying iron status. Genome-wide association study (GWAS) summary data obtained fro...
Saved in:
Published in | PLoS medicine Vol. 16; no. 6; p. e1002833 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
20.06.2019
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The objective of this study was to explore the broad clinical effects of varying iron status.
Genome-wide association study (GWAS) summary data obtained from 48,972 European individuals (55% female) across 19 cohorts in the Genetics of Iron Status Consortium were used to identify 3 genetic variants (rs1800562 and rs1799945 in the hemochromatosis gene [HFE] and rs855791 in the transmembrane protease serine 6 gene [TMPRSS6]) that associate with increased serum iron, ferritin, and transferrin saturation and decreased transferrin levels, thus serving as instruments for systemic iron status. Phenome-wide association study (PheWAS) of these instruments was performed on 424,439 European individuals (54% female) in the UK Biobank who were aged 40-69 years when recruited from 2006 to 2010, with their genetic data linked to Hospital Episode Statistics (HES) from April, 1995 to March, 2016. Two-sample summary data mendelian randomization (MR) analysis was performed to investigate the effect of varying iron status on outcomes across the human phenome. MR-PheWAS analysis for the 3 iron status genetic instruments was performed separately and then pooled by meta-analysis. Correction was made for testing of multiple correlated phenotypes using a 5% false discovery rate (FDR) threshold. Heterogeneity between MR estimates for different instruments was used to indicate possible bias due to effects of the genetic variants through pathways unrelated to iron status. There were 904 distinct phenotypes included in the MR-PheWAS analyses. After correcting for multiple testing, the 3 genetic instruments for systemic iron status demonstrated consistent evidence of a causal effect of higher iron status on decreasing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a standard deviation [SD] increase in genetically determined serum iron levels 0.72, 95% confidence interval [CI] 0.64-0.81, P = 4 × 10-8) and hypercholesterolemia (hypercholesterolemia: OR 0.88, 95% CI 0.83-0.93, P = 2 × 10-5) and increasing risk of traits related to infection of the skin and related structures (cellulitis and abscess of the leg: OR 1.25, 95% CI 1.10-1.42, P = 6 × 10-4). The main limitations of this study relate to possible bias from pleiotropic effects of the considered genetic variants and misclassification of diagnoses in the HES data. Furthermore, this work only investigated participants with European ancestry, and the findings may not be applicable to other ethnic groups.
Our findings offer novel, to our knowledge, insight into previously unreported effects of iron status, highlighting a potential protective effect of higher iron status on hypercholesterolemia and a detrimental role on risk of skin and skin structure infections. Given the modifiable and variable nature of iron status, these findings warrant further investigation. |
---|---|
AbstractList | Using Mendelian randomization, Dipender Gill and colleagues investigate the clinical implications of iron levels. Background Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The objective of this study was to explore the broad clinical effects of varying iron status. Methods and findings Genome-wide association study (GWAS) summary data obtained from 48,972 European individuals (55% female) across 19 cohorts in the Genetics of Iron Status Consortium were used to identify 3 genetic variants (rs1800562 and rs1799945 in the hemochromatosis gene [HFE] and rs855791 in the transmembrane protease serine 6 gene [TMPRSS6]) that associate with increased serum iron, ferritin, and transferrin saturation and decreased transferrin levels, thus serving as instruments for systemic iron status. Phenome-wide association study (PheWAS) of these instruments was performed on 424,439 European individuals (54% female) in the UK Biobank who were aged 40–69 years when recruited from 2006 to 2010, with their genetic data linked to Hospital Episode Statistics (HES) from April, 1995 to March, 2016. Two-sample summary data mendelian randomization (MR) analysis was performed to investigate the effect of varying iron status on outcomes across the human phenome. MR–PheWAS analysis for the 3 iron status genetic instruments was performed separately and then pooled by meta-analysis. Correction was made for testing of multiple correlated phenotypes using a 5% false discovery rate (FDR) threshold. Heterogeneity between MR estimates for different instruments was used to indicate possible bias due to effects of the genetic variants through pathways unrelated to iron status. There were 904 distinct phenotypes included in the MR–PheWAS analyses. After correcting for multiple testing, the 3 genetic instruments for systemic iron status demonstrated consistent evidence of a causal effect of higher iron status on decreasing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a standard deviation [SD] increase in genetically determined serum iron levels 0.72, 95% confidence interval [CI] 0.64–0.81, P = 4 × 10−8) and hypercholesterolemia (hypercholesterolemia: OR 0.88, 95% CI 0.83–0.93, P = 2 × 10−5) and increasing risk of traits related to infection of the skin and related structures (cellulitis and abscess of the leg: OR 1.25, 95% CI 1.10–1.42, P = 6 × 10−4). The main limitations of this study relate to possible bias from pleiotropic effects of the considered genetic variants and misclassification of diagnoses in the HES data. Furthermore, this work only investigated participants with European ancestry, and the findings may not be applicable to other ethnic groups. Conclusions Our findings offer novel, to our knowledge, insight into previously unreported effects of iron status, highlighting a potential protective effect of higher iron status on hypercholesterolemia and a detrimental role on risk of skin and skin structure infections. Given the modifiable and variable nature of iron status, these findings warrant further investigation. Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The objective of this study was to explore the broad clinical effects of varying iron status. Genome-wide association study (GWAS) summary data obtained from 48,972 European individuals (55% female) across 19 cohorts in the Genetics of Iron Status Consortium were used to identify 3 genetic variants (rs1800562 and rs1799945 in the hemochromatosis gene [HFE] and rs855791 in the transmembrane protease serine 6 gene [TMPRSS6]) that associate with increased serum iron, ferritin, and transferrin saturation and decreased transferrin levels, thus serving as instruments for systemic iron status. Phenome-wide association study (PheWAS) of these instruments was performed on 424,439 European individuals (54% female) in the UK Biobank who were aged 40-69 years when recruited from 2006 to 2010, with their genetic data linked to Hospital Episode Statistics (HES) from April, 1995 to March, 2016. Two-sample summary data mendelian randomization (MR) analysis was performed to investigate the effect of varying iron status on outcomes across the human phenome. MR-PheWAS analysis for the 3 iron status genetic instruments was performed separately and then pooled by meta-analysis. Correction was made for testing of multiple correlated phenotypes using a 5% false discovery rate (FDR) threshold. Heterogeneity between MR estimates for different instruments was used to indicate possible bias due to effects of the genetic variants through pathways unrelated to iron status. There were 904 distinct phenotypes included in the MR-PheWAS analyses. After correcting for multiple testing, the 3 genetic instruments for systemic iron status demonstrated consistent evidence of a causal effect of higher iron status on decreasing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a standard deviation [SD] increase in genetically determined serum iron levels 0.72, 95% confidence interval [CI] 0.64-0.81, P = 4 × 10-8) and hypercholesterolemia (hypercholesterolemia: OR 0.88, 95% CI 0.83-0.93, P = 2 × 10-5) and increasing risk of traits related to infection of the skin and related structures (cellulitis and abscess of the leg: OR 1.25, 95% CI 1.10-1.42, P = 6 × 10-4). The main limitations of this study relate to possible bias from pleiotropic effects of the considered genetic variants and misclassification of diagnoses in the HES data. Furthermore, this work only investigated participants with European ancestry, and the findings may not be applicable to other ethnic groups. Our findings offer novel, to our knowledge, insight into previously unreported effects of iron status, highlighting a potential protective effect of higher iron status on hypercholesterolemia and a detrimental role on risk of skin and skin structure infections. Given the modifiable and variable nature of iron status, these findings warrant further investigation. Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The objective of this study was to explore the broad clinical effects of varying iron status. Genome-wide association study (GWAS) summary data obtained from 48,972 European individuals (55% female) across 19 cohorts in the Genetics of Iron Status Consortium were used to identify 3 genetic variants (rs1800562 and rs1799945 in the hemochromatosis gene [HFE] and rs855791 in the transmembrane protease serine 6 gene [TMPRSS6]) that associate with increased serum iron, ferritin, and transferrin saturation and decreased transferrin levels, thus serving as instruments for systemic iron status. Phenome-wide association study (PheWAS) of these instruments was performed on 424,439 European individuals (54% female) in the UK Biobank who were aged 40-69 years when recruited from 2006 to 2010, with their genetic data linked to Hospital Episode Statistics (HES) from April, 1995 to March, 2016. Two-sample summary data mendelian randomization (MR) analysis was performed to investigate the effect of varying iron status on outcomes across the human phenome. MR-PheWAS analysis for the 3 iron status genetic instruments was performed separately and then pooled by meta-analysis. Correction was made for testing of multiple correlated phenotypes using a 5% false discovery rate (FDR) threshold. Heterogeneity between MR estimates for different instruments was used to indicate possible bias due to effects of the genetic variants through pathways unrelated to iron status. There were 904 distinct phenotypes included in the MR-PheWAS analyses. After correcting for multiple testing, the 3 genetic instruments for systemic iron status demonstrated consistent evidence of a causal effect of higher iron status on decreasing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a standard deviation [SD] increase in genetically determined serum iron levels 0.72, 95% confidence interval [CI] 0.64-0.81, P = 4 x 10.sup.-8) and hypercholesterolemia (hypercholesterolemia: OR 0.88, 95% CI 0.83-0.93, P = 2 x 10.sup.-5) and increasing risk of traits related to infection of the skin and related structures (cellulitis and abscess of the leg: OR 1.25, 95% CI 1.10-1.42, P = 6 x 10.sup.-4). The main limitations of this study relate to possible bias from pleiotropic effects of the considered genetic variants and misclassification of diagnoses in the HES data. Furthermore, this work only investigated participants with European ancestry, and the findings may not be applicable to other ethnic groups. Our findings offer novel, to our knowledge, insight into previously unreported effects of iron status, highlighting a potential protective effect of higher iron status on hypercholesterolemia and a detrimental role on risk of skin and skin structure infections. Given the modifiable and variable nature of iron status, these findings warrant further investigation. BackgroundIron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The objective of this study was to explore the broad clinical effects of varying iron status.Methods and findingsGenome-wide association study (GWAS) summary data obtained from 48,972 European individuals (55% female) across 19 cohorts in the Genetics of Iron Status Consortium were used to identify 3 genetic variants (rs1800562 and rs1799945 in the hemochromatosis gene [HFE] and rs855791 in the transmembrane protease serine 6 gene [TMPRSS6]) that associate with increased serum iron, ferritin, and transferrin saturation and decreased transferrin levels, thus serving as instruments for systemic iron status. Phenome-wide association study (PheWAS) of these instruments was performed on 424,439 European individuals (54% female) in the UK Biobank who were aged 40-69 years when recruited from 2006 to 2010, with their genetic data linked to Hospital Episode Statistics (HES) from April, 1995 to March, 2016. Two-sample summary data mendelian randomization (MR) analysis was performed to investigate the effect of varying iron status on outcomes across the human phenome. MR-PheWAS analysis for the 3 iron status genetic instruments was performed separately and then pooled by meta-analysis. Correction was made for testing of multiple correlated phenotypes using a 5% false discovery rate (FDR) threshold. Heterogeneity between MR estimates for different instruments was used to indicate possible bias due to effects of the genetic variants through pathways unrelated to iron status. There were 904 distinct phenotypes included in the MR-PheWAS analyses. After correcting for multiple testing, the 3 genetic instruments for systemic iron status demonstrated consistent evidence of a causal effect of higher iron status on decreasing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a standard deviation [SD] increase in genetically determined serum iron levels 0.72, 95% confidence interval [CI] 0.64-0.81, P = 4 × 10-8) and hypercholesterolemia (hypercholesterolemia: OR 0.88, 95% CI 0.83-0.93, P = 2 × 10-5) and increasing risk of traits related to infection of the skin and related structures (cellulitis and abscess of the leg: OR 1.25, 95% CI 1.10-1.42, P = 6 × 10-4). The main limitations of this study relate to possible bias from pleiotropic effects of the considered genetic variants and misclassification of diagnoses in the HES data. Furthermore, this work only investigated participants with European ancestry, and the findings may not be applicable to other ethnic groups.ConclusionsOur findings offer novel, to our knowledge, insight into previously unreported effects of iron status, highlighting a potential protective effect of higher iron status on hypercholesterolemia and a detrimental role on risk of skin and skin structure infections. Given the modifiable and variable nature of iron status, these findings warrant further investigation. Background Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The objective of this study was to explore the broad clinical effects of varying iron status. Methods and findings Genome-wide association study (GWAS) summary data obtained from 48,972 European individuals (55% female) across 19 cohorts in the Genetics of Iron Status Consortium were used to identify 3 genetic variants (rs1800562 and rs1799945 in the hemochromatosis gene [HFE] and rs855791 in the transmembrane protease serine 6 gene [TMPRSS6]) that associate with increased serum iron, ferritin, and transferrin saturation and decreased transferrin levels, thus serving as instruments for systemic iron status. Phenome-wide association study (PheWAS) of these instruments was performed on 424,439 European individuals (54% female) in the UK Biobank who were aged 40-69 years when recruited from 2006 to 2010, with their genetic data linked to Hospital Episode Statistics (HES) from April, 1995 to March, 2016. Two-sample summary data mendelian randomization (MR) analysis was performed to investigate the effect of varying iron status on outcomes across the human phenome. MR-PheWAS analysis for the 3 iron status genetic instruments was performed separately and then pooled by meta-analysis. Correction was made for testing of multiple correlated phenotypes using a 5% false discovery rate (FDR) threshold. Heterogeneity between MR estimates for different instruments was used to indicate possible bias due to effects of the genetic variants through pathways unrelated to iron status. There were 904 distinct phenotypes included in the MR-PheWAS analyses. After correcting for multiple testing, the 3 genetic instruments for systemic iron status demonstrated consistent evidence of a causal effect of higher iron status on decreasing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a standard deviation [SD] increase in genetically determined serum iron levels 0.72, 95% confidence interval [CI] 0.64-0.81, P = 4 x 10.sup.-8) and hypercholesterolemia (hypercholesterolemia: OR 0.88, 95% CI 0.83-0.93, P = 2 x 10.sup.-5) and increasing risk of traits related to infection of the skin and related structures (cellulitis and abscess of the leg: OR 1.25, 95% CI 1.10-1.42, P = 6 x 10.sup.-4). The main limitations of this study relate to possible bias from pleiotropic effects of the considered genetic variants and misclassification of diagnoses in the HES data. Furthermore, this work only investigated participants with European ancestry, and the findings may not be applicable to other ethnic groups. Conclusions Our findings offer novel, to our knowledge, insight into previously unreported effects of iron status, highlighting a potential protective effect of higher iron status on hypercholesterolemia and a detrimental role on risk of skin and skin structure infections. Given the modifiable and variable nature of iron status, these findings warrant further investigation. Background Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The objective of this study was to explore the broad clinical effects of varying iron status. Methods and findings Genome-wide association study (GWAS) summary data obtained from 48,972 European individuals (55% female) across 19 cohorts in the Genetics of Iron Status Consortium were used to identify 3 genetic variants (rs1800562 and rs1799945 in the hemochromatosis gene [HFE] and rs855791 in the transmembrane protease serine 6 gene [TMPRSS6]) that associate with increased serum iron, ferritin, and transferrin saturation and decreased transferrin levels, thus serving as instruments for systemic iron status. Phenome-wide association study (PheWAS) of these instruments was performed on 424,439 European individuals (54% female) in the UK Biobank who were aged 40–69 years when recruited from 2006 to 2010, with their genetic data linked to Hospital Episode Statistics (HES) from April, 1995 to March, 2016. Two-sample summary data mendelian randomization (MR) analysis was performed to investigate the effect of varying iron status on outcomes across the human phenome. MR–PheWAS analysis for the 3 iron status genetic instruments was performed separately and then pooled by meta-analysis. Correction was made for testing of multiple correlated phenotypes using a 5% false discovery rate (FDR) threshold. Heterogeneity between MR estimates for different instruments was used to indicate possible bias due to effects of the genetic variants through pathways unrelated to iron status. There were 904 distinct phenotypes included in the MR–PheWAS analyses. After correcting for multiple testing, the 3 genetic instruments for systemic iron status demonstrated consistent evidence of a causal effect of higher iron status on decreasing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a standard deviation [SD] increase in genetically determined serum iron levels 0.72, 95% confidence interval [CI] 0.64–0.81, P = 4 × 10−8) and hypercholesterolemia (hypercholesterolemia: OR 0.88, 95% CI 0.83–0.93, P = 2 × 10−5) and increasing risk of traits related to infection of the skin and related structures (cellulitis and abscess of the leg: OR 1.25, 95% CI 1.10–1.42, P = 6 × 10−4). The main limitations of this study relate to possible bias from pleiotropic effects of the considered genetic variants and misclassification of diagnoses in the HES data. Furthermore, this work only investigated participants with European ancestry, and the findings may not be applicable to other ethnic groups. Conclusions Our findings offer novel, to our knowledge, insight into previously unreported effects of iron status, highlighting a potential protective effect of higher iron status on hypercholesterolemia and a detrimental role on risk of skin and skin structure infections. Given the modifiable and variable nature of iron status, these findings warrant further investigation. |
Audience | Academic |
Author | Benyamin, Beben Laffan, Mike Elliott, Paul Monori, Grace Gill, Dipender Zhou, Ang Koskeridis, Fotios Evangelou, Evangelos Dehghan, Abbas Tzoulaki, Ioanna Walker, Ann P Tsilidis, Konstantinos K Hyppönen, Elina Moore, Luke S P |
AuthorAffiliation | 11 Medical Research Council-Public Health England Centre for Environment, School of Public Health, Imperial College London, London, United Kingdom 13 Health Data Research UK-London, London, United Kingdom 6 Chelsea & Westminster NHS Foundation Trust, London, United Kingdom 12 UK Dementia Research Institute, Imperial College London, London, United Kingdom 8 Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece 14 Population, Policy and Practice, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom University of Oxford, UNITED KINGDOM 1 Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom 9 Centre for Haematology, Imperial College London, United Kingdom 5 National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, United Kingdom 7 Imperial Biomedic |
AuthorAffiliation_xml | – name: 13 Health Data Research UK-London, London, United Kingdom – name: 6 Chelsea & Westminster NHS Foundation Trust, London, United Kingdom – name: 2 Australian Centre for Precision Health, University of South Australia, Adelaide, Australia – name: 7 Imperial Biomedical Research Centre, Imperial College London and Imperial College NHS Healthcare Trust, London, United Kingdom – name: 3 Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia – name: 9 Centre for Haematology, Imperial College London, United Kingdom – name: 4 South Australian Health and Medical Research Institute, Adelaide, Australia – name: 5 National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, United Kingdom – name: 12 UK Dementia Research Institute, Imperial College London, London, United Kingdom – name: University of Oxford, UNITED KINGDOM – name: 11 Medical Research Council-Public Health England Centre for Environment, School of Public Health, Imperial College London, London, United Kingdom – name: 8 Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece – name: 10 Population Science & Experimental Medicine, Institute of Cardiovascular Science, University College London, London, United Kingdom – name: 1 Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom – name: 14 Population, Policy and Practice, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom |
Author_xml | – sequence: 1 givenname: Dipender orcidid: 0000-0001-7312-7078 surname: Gill fullname: Gill, Dipender organization: Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom – sequence: 2 givenname: Beben orcidid: 0000-0001-5608-2293 surname: Benyamin fullname: Benyamin, Beben organization: South Australian Health and Medical Research Institute, Adelaide, Australia – sequence: 3 givenname: Luke S P orcidid: 0000-0001-7095-7922 surname: Moore fullname: Moore, Luke S P organization: Imperial Biomedical Research Centre, Imperial College London and Imperial College NHS Healthcare Trust, London, United Kingdom – sequence: 4 givenname: Grace surname: Monori fullname: Monori, Grace organization: Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom – sequence: 5 givenname: Ang surname: Zhou fullname: Zhou, Ang organization: Australian Centre for Precision Health, University of South Australia, Adelaide, Australia – sequence: 6 givenname: Fotios surname: Koskeridis fullname: Koskeridis, Fotios organization: Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece – sequence: 7 givenname: Evangelos orcidid: 0000-0002-5488-2999 surname: Evangelou fullname: Evangelou, Evangelos organization: Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece – sequence: 8 givenname: Mike surname: Laffan fullname: Laffan, Mike organization: Centre for Haematology, Imperial College London, United Kingdom – sequence: 9 givenname: Ann P surname: Walker fullname: Walker, Ann P organization: Population Science & Experimental Medicine, Institute of Cardiovascular Science, University College London, London, United Kingdom – sequence: 10 givenname: Konstantinos K orcidid: 0000-0002-8452-8472 surname: Tsilidis fullname: Tsilidis, Konstantinos K organization: Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece – sequence: 11 givenname: Abbas orcidid: 0000-0001-6403-016X surname: Dehghan fullname: Dehghan, Abbas organization: UK Dementia Research Institute, Imperial College London, London, United Kingdom – sequence: 12 givenname: Paul surname: Elliott fullname: Elliott, Paul organization: Health Data Research UK-London, London, United Kingdom – sequence: 13 givenname: Elina orcidid: 0000-0003-3670-9399 surname: Hyppönen fullname: Hyppönen, Elina organization: Population, Policy and Practice, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom – sequence: 14 givenname: Ioanna orcidid: 0000-0002-4275-9328 surname: Tzoulaki fullname: Tzoulaki, Ioanna organization: Medical Research Council-Public Health England Centre for Environment, School of Public Health, Imperial College London, London, United Kingdom |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31220083$$D View this record in MEDLINE/PubMed |
BookMark | eNqVk1uL1DAUx4usuBf9BqIFQfRhxjRp2sQHYVi8DCwueHsNaXMykyVNZptWHD-96Ux3mco8KHloSH_nf-7nyYnzDpLkaYbmGSmzNze-b520800Dap4hhBkhD5KzjOZ8lhVlcXJwP03OQ7iJDEccPUpOSYYxQoycJXoRgq-N7Ix3IfU6XYGDztTS2m2qoIO2MQ5Ualrv0tDJrg-prFsfQtqtId2swfkG3qaLtAGnwBrp0lY65RvzeycajXq1fZw81NIGeDJ-L5LvH95_u_w0u7r-uLxcXM1qRlA3U5rholIaE8pKJesYsSSsopwUpVYxEShrmfEIcF1SLVFOGWY8QxXUecUouUie73U31gcxligIjKMep5yzSCz3hPLyRmxa08h2K7w0Yvfg25WQbSyABYGkqmilKyBQ5JSXTGHFKlVqiH6LPI9a70ZvfRW7UIPrWmknotM_zqzFyv8UBWUFpmUUeDUKtP62h9CJxoQarJUOfD_EHR1RnJdFRF_8hR7PbqRWMiZgnPbRbz2IigXlOM4C4YPb2RFq6HwMMk6ZNvF5ws-P8PEoaEx91OD1xCAyHfzqVrIPQSy_fvkP9vO_s9c_puzLA3YN0nbr4G2_m_QpmO_B3Vi3oO8bmCExrNpdpcWwamJctWj27LD590Z3u0X-ACzQJbw |
CitedBy_id | crossref_primary_10_1016_j_clnu_2020_05_044 crossref_primary_10_1080_03007995_2021_2012965 crossref_primary_10_1016_j_xhgg_2020_100010 crossref_primary_10_1016_j_placenta_2022_09_010 crossref_primary_10_1136_bmjgast_2023_001236 crossref_primary_10_1093_ije_dyac037 crossref_primary_10_1212_NXG_0000000000000422 crossref_primary_10_1093_ajcn_nqab003 crossref_primary_10_1093_advances_nmab035 crossref_primary_10_1038_s41598_023_29641_6 crossref_primary_10_1101_mcs_a004531 crossref_primary_10_1161_JAHA_124_034991 crossref_primary_10_1016_j_clinre_2019_09_007 crossref_primary_10_1038_s41366_023_01299_0 crossref_primary_10_1016_j_clnu_2020_06_025 crossref_primary_10_1210_clinem_dgab454 crossref_primary_10_1093_jn_nxab015 crossref_primary_10_3390_ijms24098309 crossref_primary_10_1016_j_jfutfo_2022_12_001 crossref_primary_10_1038_s41598_022_20679_6 crossref_primary_10_3390_ijms24097799 crossref_primary_10_1007_s43657_022_00052_3 crossref_primary_10_1089_ars_2020_8167 crossref_primary_10_1016_j_nut_2023_112295 crossref_primary_10_3389_fgene_2021_729326 crossref_primary_10_1016_j_eclinm_2020_100498 crossref_primary_10_1186_s12916_023_02780_3 crossref_primary_10_1016_j_clnu_2022_02_020 crossref_primary_10_1161_JAHA_123_031732 crossref_primary_10_1016_j_cej_2023_141837 crossref_primary_10_1186_s12916_023_03018_y crossref_primary_10_1186_s13098_024_01304_0 crossref_primary_10_1016_j_jid_2023_07_009 crossref_primary_10_1038_s42003_022_03529_z crossref_primary_10_1093_ije_dyad093 crossref_primary_10_1210_clinem_dgad089 crossref_primary_10_1038_s41573_022_00561_w crossref_primary_10_12688_wellcomeopenres_15555_1 crossref_primary_10_12688_wellcomeopenres_18829_1 crossref_primary_10_1093_aje_kwad154 crossref_primary_10_12688_wellcomeopenres_15555_3 crossref_primary_10_12688_wellcomeopenres_15555_2 crossref_primary_10_3390_nu12103174 crossref_primary_10_1002_mds_28765 crossref_primary_10_3390_genes13010005 |
Cites_doi | 10.1038/srep16670 10.1177/0962280210394459 10.1038/srep16645 10.1111/j.2517-6161.1995.tb02031.x 10.1038/nbt.2749 10.1128/IAI.72.1.29-37.2004 10.1007/s11745-998-0285-8 10.1161/ATVBAHA.117.309757 10.1371/journal.pmed.1001462 10.2215/CJN.01490506 10.1136/annrheumdis-2017-212534 10.1016/j.ehb.2013.12.002 10.1002/sim.6522 10.1093/bioinformatics/btv402 10.1128/IAI.00602-13 10.1016/j.mcna.2016.09.004 10.1038/ncomms5926 10.1038/nature09270 10.1016/S0140-6736(18)32335-3 10.1016/S0140-6736(16)31678-6 10.1016/j.jfma.2013.11.010 10.1185/03007995.2012.761599 10.1039/c1mt00082a 10.7554/eLife.34408 10.1093/ije/dyw088 10.1515/ijb-2015-0074 10.1136/bmj.k5222 10.1136/bmj.h2258 10.1186/s12859-018-2135-0 10.1136/bmj.330.7499.1076 10.3748/wjg.v18.i34.4651 10.1016/j.cell.2004.11.032 10.1093/ije/dyt179 10.1097/EDE.0000000000000559 10.1080/19390211.2018.1474987 10.1128/IAI.71.3.1042-1055.2003 10.1002/gepi.21758 10.1371/journal.pmed.1001779 10.1002/gepi.21965 10.1161/STROKEAHA.118.022701 10.1371/journal.pone.0175508 10.1016/j.ijid.2007.04.007 10.1136/bmj.k601 10.1007/s10654-018-0442-4 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2019 Public Library of Science 2019 Gill et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2019 Gill et al 2019 Gill et al |
Copyright_xml | – notice: COPYRIGHT 2019 Public Library of Science – notice: 2019 Gill et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2019 Gill et al 2019 Gill et al |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION IOV ISN ISR 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA CZK |
DOI | 10.1371/journal.pmed.1002833 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Opposing Viewpoints Resource Center Gale In Context: Canada Gale In Context: Science ProQuest Central (Corporate) Neurosciences Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals PLoS Medicine |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 7X7 name: ProQuest Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
DocumentTitleAlternate | Phenome-wide associations of iron status: Mendelian randomization study |
EISSN | 1549-1676 |
Editor | Rahimi, Kazem |
Editor_xml | – sequence: 1 givenname: Kazem surname: Rahimi fullname: Rahimi, Kazem |
EndPage | e1002833 |
ExternalDocumentID | 2258795998 oai_doaj_org_article_0adb5bfbe3e645978d2d8bd7fe045644 A592167397 10_1371_journal_pmed_1002833 31220083 |
Genre | Research Support, Non-U.S. Gov't Journal Article Observational Study |
GeographicLocations | Europe Greece United Kingdom--UK Australia Adelaide South Australia Australia |
GeographicLocations_xml | – name: Europe – name: Adelaide South Australia Australia – name: United Kingdom--UK – name: Greece – name: Australia |
GrantInformation_xml | – fundername: Wellcome Trust – fundername: Department of Health – fundername: Medical Research Council grantid: MR/L01341X/1 |
GroupedDBID | --- 123 29O 2WC 3V. 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAWTL ABDBF ABUWG ACGFO ACIHN ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFPKN AFRAH AFXKF AHMBA AKRSQ ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAWUL BCGST BCNDV BENPR BPHCQ BVXVI BWKFM CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EAP EAS EBD EBS ECM EIF EJD EMK EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO ICW IHR IHW INH INR IOF IOV IPNFZ IPO ISN ISR ITC KQ8 M1P M48 MK0 M~E NPM O5R O5S OK1 P2P PIMPY PQQKQ PROAC PSQYO PV9 RIG RNS RPM RZL SV3 TR2 TUS UKHRP WOQ WOW XSB YZZ ~8M AAYXX CITATION 7TK 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 5PM AAPBV ABPTK CZK |
ID | FETCH-LOGICAL-c830t-df826bdf23587dac002a38b59367fd676e7ca19df29f75fa045828910bec4b853 |
IEDL.DBID | RPM |
ISSN | 1549-1676 1549-1277 |
IngestDate | Sun Nov 05 00:20:30 EDT 2023 Thu Jul 04 21:10:29 EDT 2024 Tue Sep 17 21:25:35 EDT 2024 Sat Jun 22 20:20:28 EDT 2024 Fri Sep 13 03:34:54 EDT 2024 Thu Feb 22 23:54:09 EST 2024 Fri Feb 02 04:56:34 EST 2024 Fri Feb 02 04:19:01 EST 2024 Thu Aug 01 19:58:27 EDT 2024 Thu Aug 01 20:06:08 EDT 2024 Thu Aug 01 20:20:42 EDT 2024 Tue Aug 20 22:11:54 EDT 2024 Wed Jul 24 12:28:03 EDT 2024 Sun Jun 23 00:37:02 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c830t-df826bdf23587dac002a38b59367fd676e7ca19df29f75fa045828910bec4b853 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 These authors contributed equally and are joint first authors. I have read the journal's policy and the authors of this manuscript have the following competing interests: LSPM has consulted for bioMerieux (2014), DNAelectronics (2015-2018), Dairy Crest (2017-2018), and Pfizer (2018) and has received research grants from Leo Pharma (2016) and educational support from Eumedica (2016-2017). All other authors have no competing interest to declare. |
ORCID | 0000-0002-4275-9328 0000-0002-5488-2999 0000-0003-3670-9399 0000-0001-7312-7078 0000-0001-5608-2293 0000-0001-7095-7922 0000-0002-8452-8472 0000-0001-6403-016X |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586257/ |
PMID | 31220083 |
PQID | 2258795998 |
PQPubID | 1436338 |
ParticipantIDs | plos_journals_2258795998 doaj_primary_oai_doaj_org_article_0adb5bfbe3e645978d2d8bd7fe045644 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6586257 proquest_miscellaneous_2245652476 proquest_journals_2258795998 gale_infotracmisc_A592167397 gale_infotracgeneralonefile_A592167397 gale_infotracacademiconefile_A592167397 gale_incontextgauss_ISR_A592167397 gale_incontextgauss_ISN_A592167397 gale_incontextgauss_IOV_A592167397 gale_healthsolutions_A592167397 crossref_primary_10_1371_journal_pmed_1002833 pubmed_primary_31220083 |
PublicationCentury | 2000 |
PublicationDate | 20190620 |
PublicationDateYYYYMMDD | 2019-06-20 |
PublicationDate_xml | – month: 6 year: 2019 text: 20190620 day: 20 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PLoS medicine |
PublicationTitleAlternate | PLoS Med |
PublicationYear | 2019 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | FPN Arcanjo (ref49) 2018 WQ Wei (ref20) 2017; 12 M F Del Greco (ref27) 2015; 34 LM De-Regil (ref48) 2017; 11 FA Khan (ref34) 2007; 11 (ref36) 2018; 392 JR Thompson (ref25) 2016; 12 D Gill (ref8) 2017; 37 E Poggiali (ref51) 2012; 10 JH Cross (ref35) 2015; 5 GI Stangl (ref40) 1998; 33 I Pichler (ref9) 2013; 10 G Hemani (ref30) 2018; 7 LC Pilling (ref42) 2019; 364 AE Taylor (ref13) 2014; 13 JB Wish (ref15) 2006; 1 K Jimenez (ref46) 2015; 11 J Ma (ref55) 2012 CS Bates (ref32) 2003; 71 J Bowden (ref29) 2016; 40 JC Denny (ref12) 2013; 31 MJ Cancelo-Hidalgo (ref47) 2013; 29 (ref3) 2016; 388 S Burgess (ref28) 2017; 28 LAC Millard (ref11) 2015; 5 A. Koga (ref38) 1985; 66 MS Low (ref52) 2016; 4 MJ Brion (ref23) 2013; 42 NM Davies (ref7) 2018; 362 U Ahmed (ref41) 2012; 18 TB Assi (ref50) 2014; 12 N Abbaspour (ref1) 2014; 19 J Bowden (ref43) 2018; 187 B Benyamin (ref2) 2014; 5 NL Parrow (ref33) 2013; 81 DI Swerdlow (ref16) 2016; 45 JP Pena-Rosas (ref53) 2015 S Puig (ref14) 2005; 120 X Li (ref21) 2018; 77 A Neuberger (ref56) 2016; 2 SE Dale (ref31) 2004; 72 LM Trotti (ref57) 2012 TM Palmer (ref18) 2012; 21 MJ Machiela (ref17) 2015; 31 G Sebastiani (ref5) 2011; 3 D Gill (ref10) 2018; 49 A Verma (ref22) 2018; 19 TG DeLoughery (ref4) 2017; 101 S Padmanabhan (ref44) 2019; 34 TM Teslovich (ref39) 2010; 466 S Padhi (ref54) 2015; 350 C Sudlow (ref19) 2015; 12 Y Benjamini (ref26) 1995; 57 YC Wu (ref45) 2014; 113 S Burgess (ref24) 2013; 37 G Davey Smith (ref6) 2005; 330 C Mercado (ref37) 2015; 64 |
References_xml | – volume: 5 start-page: 16670 year: 2015 ident: ref35 article-title: Oral iron acutely elevates bacterial growth in human serum publication-title: Sci Rep doi: 10.1038/srep16670 contributor: fullname: JH Cross – volume: 21 start-page: 223 issue: 3 year: 2012 ident: ref18 article-title: Using multiple genetic variants as instrumental variables for modifiable risk factors publication-title: Stat Methods Med Res doi: 10.1177/0962280210394459 contributor: fullname: TM Palmer – volume: 4 start-page: CD009747 year: 2016 ident: ref52 article-title: Daily iron supplementation for improving anaemia, iron status and health in menstruating women publication-title: Cochrane Database Syst Rev contributor: fullname: MS Low – volume: 5 start-page: 16645 year: 2015 ident: ref11 article-title: MR-PheWAS: hypothesis prioritization among potential causal effects of body mass index on many outcomes, using Mendelian randomization publication-title: Sci Rep doi: 10.1038/srep16645 contributor: fullname: LAC Millard – volume: 57 start-page: 289 issue: 1 year: 1995 ident: ref26 article-title: Controlling the False Discovery Rate—a Practical and Powerful Approach to Multiple Testing publication-title: J Roy Stat Soc B Met doi: 10.1111/j.2517-6161.1995.tb02031.x contributor: fullname: Y Benjamini – volume: 31 start-page: 1102 issue: 12 year: 2013 ident: ref12 article-title: Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data publication-title: Nat Biotechnol doi: 10.1038/nbt.2749 contributor: fullname: JC Denny – start-page: CD007834 issue: 5 year: 2012 ident: ref57 article-title: Iron for restless legs syndrome. Cochrane Database Syst Rev contributor: fullname: LM Trotti – volume: 11 start-page: 241 issue: 4 year: 2015 ident: ref46 article-title: Management of Iron Deficiency Anemia publication-title: Gastroenterol Hepatol (N Y) contributor: fullname: K Jimenez – volume: 72 start-page: 29 issue: 1 year: 2004 ident: ref31 article-title: Role of siderophore biosynthesis in virulence of Staphylococcus aureus: identification and characterization of genes involved in production of a siderophore publication-title: Infect Immun doi: 10.1128/IAI.72.1.29-37.2004 contributor: fullname: SE Dale – volume: 33 start-page: 889 issue: 9 year: 1998 ident: ref40 article-title: Different degrees of moderate iron deficiency modulate lipid metabolism of rats publication-title: Lipids doi: 10.1007/s11745-998-0285-8 contributor: fullname: GI Stangl – volume: 37 start-page: 1788 issue: 9 year: 2017 ident: ref8 article-title: The effect of iron status on risk of coronary artery disease: a mendelian randomization study publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.117.309757 contributor: fullname: D Gill – volume: 10 start-page: e1001462 issue: 6 year: 2013 ident: ref9 article-title: Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study publication-title: PLoS Med doi: 10.1371/journal.pmed.1001462 contributor: fullname: I Pichler – volume: 10 start-page: 411 issue: 4 year: 2012 ident: ref51 article-title: An update on iron chelation therapy publication-title: Blood Transfus contributor: fullname: E Poggiali – volume: 1 start-page: S4 issue: Suppl 1 year: 2006 ident: ref15 article-title: Assessing iron status: beyond serum ferritin and transferrin saturation publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.01490506 contributor: fullname: JB Wish – volume: 77 start-page: 1039 issue: 7 year: 2018 ident: ref21 article-title: MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2017-212534 contributor: fullname: X Li – volume: 13 start-page: 99 year: 2014 ident: ref13 article-title: Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates publication-title: Econ Hum Biol doi: 10.1016/j.ehb.2013.12.002 contributor: fullname: AE Taylor – volume: 34 start-page: 2926 issue: 21 year: 2015 ident: ref27 article-title: Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome publication-title: Stat Med doi: 10.1002/sim.6522 contributor: fullname: M F Del Greco – volume: 31 start-page: 3555 issue: 21 year: 2015 ident: ref17 article-title: LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants publication-title: Bioinformatics doi: 10.1093/bioinformatics/btv402 contributor: fullname: MJ Machiela – volume: 81 start-page: 3503 issue: 10 year: 2013 ident: ref33 article-title: Sequestration and scavenging of iron in infection publication-title: Infect Immun doi: 10.1128/IAI.00602-13 contributor: fullname: NL Parrow – volume: 101 start-page: 319 issue: 2 year: 2017 ident: ref4 article-title: Iron Deficiency Anemia publication-title: Med Clin North Am doi: 10.1016/j.mcna.2016.09.004 contributor: fullname: TG DeLoughery – volume: 5 start-page: 4926 year: 2014 ident: ref2 article-title: Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis publication-title: Nat Commun doi: 10.1038/ncomms5926 contributor: fullname: B Benyamin – volume: 466 start-page: 707 issue: 7307 year: 2010 ident: ref39 article-title: Biological, clinical and population relevance of 95 loci for blood lipids publication-title: Nature doi: 10.1038/nature09270 contributor: fullname: TM Teslovich – volume: 392 start-page: 1859 issue: 10159 year: 2018 ident: ref36 article-title: Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet doi: 10.1016/S0140-6736(18)32335-3 – volume: 66 start-page: 605 issue: 5 year: 1985 ident: ref38 article-title: Fine-Structure of the Human Gallbladder with Cholesterosis with Special Reference to the Mechanism of Lipid-Accumulation publication-title: Brit J Exp Pathol contributor: fullname: A. Koga – start-page: CD004736 issue: 7 year: 2015 ident: ref53 article-title: Daily oral iron supplementation during pregnancy publication-title: Cochrane Database Syst Rev contributor: fullname: JP Pena-Rosas – volume: 19 start-page: 164 issue: 2 year: 2014 ident: ref1 article-title: Review on iron and its importance for human health publication-title: J Res Med Sci contributor: fullname: N Abbaspour – volume: 388 start-page: 1545 issue: 10053 year: 2016 ident: ref3 article-title: Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 publication-title: Lancet doi: 10.1016/S0140-6736(16)31678-6 – volume: 64 start-page: 1305 issue: 47 year: 2015 ident: ref37 article-title: Prevalence of Cholesterol Treatment Eligibility and Medication Use Among Adults—United States, 2005–2012 publication-title: MMWR contributor: fullname: C Mercado – volume: 113 start-page: 83 issue: 2 year: 2014 ident: ref45 article-title: Oral manifestations and blood profile in patients with iron deficiency anemia publication-title: J Formos Med Assoc doi: 10.1016/j.jfma.2013.11.010 contributor: fullname: YC Wu – volume: 29 start-page: 291 issue: 4 year: 2013 ident: ref47 article-title: Tolerability of different oral iron supplements: a systematic review publication-title: Curr Med Res Opin doi: 10.1185/03007995.2012.761599 contributor: fullname: MJ Cancelo-Hidalgo – volume: 12 start-page: s75 issue: Suppl 1 year: 2014 ident: ref50 article-title: Current applications of therapeutic phlebotomy publication-title: Blood Transfus contributor: fullname: TB Assi – volume: 3 start-page: 971 issue: 10 year: 2011 ident: ref5 article-title: Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice publication-title: Metallomics doi: 10.1039/c1mt00082a contributor: fullname: G Sebastiani – volume: 7 start-page: e34408 year: 2018 ident: ref30 article-title: The MR-Base platform supports systematic causal inference across the human phenome publication-title: eLife doi: 10.7554/eLife.34408 contributor: fullname: G Hemani – start-page: CD009280 issue: 9 year: 2012 ident: ref55 article-title: Iron chelators for acute stroke publication-title: Cochrane Database Syst Rev contributor: fullname: J Ma – volume: 45 start-page: 1600 issue: 5 year: 2016 ident: ref16 article-title: Selecting instruments for Mendelian randomization in the wake of genome-wide association studies publication-title: Int J Epidemiol doi: 10.1093/ije/dyw088 contributor: fullname: DI Swerdlow – volume: 12 issue: 2 year: 2016 ident: ref25 article-title: Mendelian Randomization using Public Data from Genetic Consortia publication-title: Int J Biostat doi: 10.1515/ijb-2015-0074 contributor: fullname: JR Thompson – volume: 364 start-page: k5222 year: 2019 ident: ref42 article-title: Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank publication-title: BMJ doi: 10.1136/bmj.k5222 contributor: fullname: LC Pilling – volume: 2 start-page: CD006589 year: 2016 ident: ref56 article-title: Oral iron supplements for children in malaria-endemic areas publication-title: Cochrane Database Syst Rev contributor: fullname: A Neuberger – volume: 350 start-page: h2258 year: 2015 ident: ref54 article-title: Management of anaemia in chronic kidney disease: summary of updated NICE guidance publication-title: BMJ doi: 10.1136/bmj.h2258 contributor: fullname: S Padhi – volume: 19 start-page: 120 issue: 1 year: 2018 ident: ref22 article-title: A simulation study investigating power estimates in phenome-wide association studies publication-title: BMC Bioinformatics doi: 10.1186/s12859-018-2135-0 contributor: fullname: A Verma – volume: 187 start-page: 2681 issue: 12 year: 2018 ident: ref43 article-title: Detecting individual and global horizontal pleiotropy in Mendelian randomization: a job for the humble heterogeneity statistic? publication-title: Am J Epidemiol contributor: fullname: J Bowden – volume: 330 start-page: 1076 issue: 7499 year: 2005 ident: ref6 article-title: What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? publication-title: BMJ doi: 10.1136/bmj.330.7499.1076 contributor: fullname: G Davey Smith – volume: 18 start-page: 4651 issue: 34 year: 2012 ident: ref41 article-title: Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis publication-title: World J Gastroenterol doi: 10.3748/wjg.v18.i34.4651 contributor: fullname: U Ahmed – volume: 120 start-page: 99 issue: 1 year: 2005 ident: ref14 article-title: Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation publication-title: Cell doi: 10.1016/j.cell.2004.11.032 contributor: fullname: S Puig – volume: 11 start-page: CD009666 year: 2017 ident: ref48 article-title: Point-of-use fortification of foods with micronutrient powders containing iron in children of preschool and school-age publication-title: Cochrane Database Syst Rev contributor: fullname: LM De-Regil – volume: 42 start-page: 1497 issue: 5 year: 2013 ident: ref23 article-title: Calculating statistical power in Mendelian randomization studies publication-title: Int J Epidemiol doi: 10.1093/ije/dyt179 contributor: fullname: MJ Brion – volume: 28 start-page: 30 issue: 1 year: 2017 ident: ref28 article-title: Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants publication-title: Epidemiology doi: 10.1097/EDE.0000000000000559 contributor: fullname: S Burgess – start-page: 1 year: 2018 ident: ref49 article-title: Micronutrient Fortification at Child-Care Centers Reduces Anemia in Young Children publication-title: J Diet Suppl doi: 10.1080/19390211.2018.1474987 contributor: fullname: FPN Arcanjo – volume: 71 start-page: 1042 issue: 3 year: 2003 ident: ref32 article-title: Identification and characterization of a Streptococcus pyogenes operon involved in binding of hemoproteins and acquisition of iron publication-title: Infect Immun doi: 10.1128/IAI.71.3.1042-1055.2003 contributor: fullname: CS Bates – volume: 37 start-page: 658 issue: 7 year: 2013 ident: ref24 article-title: Mendelian randomization analysis with multiple genetic variants using summarized data publication-title: Genet Epidemiol doi: 10.1002/gepi.21758 contributor: fullname: S Burgess – volume: 12 start-page: e1001779 issue: 3 year: 2015 ident: ref19 article-title: UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age publication-title: PLoS Med doi: 10.1371/journal.pmed.1001779 contributor: fullname: C Sudlow – volume: 40 start-page: 304 issue: 4 year: 2016 ident: ref29 article-title: Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator publication-title: Genet Epidemiol doi: 10.1002/gepi.21965 contributor: fullname: J Bowden – volume: 49 start-page: 2815 issue: 12 year: 2018 ident: ref10 article-title: Iron Status and Risk of Stroke publication-title: Stroke doi: 10.1161/STROKEAHA.118.022701 contributor: fullname: D Gill – volume: 12 start-page: e0175508 issue: 7 year: 2017 ident: ref20 article-title: Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenome-wide association studies in the electronic health record publication-title: PLoS ONE doi: 10.1371/journal.pone.0175508 contributor: fullname: WQ Wei – volume: 11 start-page: 482 issue: 6 year: 2007 ident: ref34 article-title: Association of hemochromatosis with infectious diseases: expanding spectrum publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2007.04.007 contributor: fullname: FA Khan – volume: 362 start-page: k601 year: 2018 ident: ref7 article-title: Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians publication-title: BMJ doi: 10.1136/bmj.k601 contributor: fullname: NM Davies – volume: 34 start-page: 91 issue: 1 year: 2019 ident: ref44 article-title: Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications publication-title: Eur J Epidemiol doi: 10.1007/s10654-018-0442-4 contributor: fullname: S Padmanabhan |
SSID | ssj0029090 |
Score | 2.534341 |
Snippet | Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The objective... Background Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The... BACKGROUNDIron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The... Using Mendelian randomization, Dipender Gill and colleagues investigate the clinical implications of iron levels. BackgroundIron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The... Background Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The... |
SourceID | plos doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e1002833 |
SubjectTerms | Adult Aged Anemia Bias Biology and Life Sciences Biomarkers - blood Biomedical research Cardiovascular disease Cellulitis Cohort Studies Councils Dementia Demographic aspects Epidemiology Female Ferritin Genes Genetic aspects Genetic diversity Genetic research Genetic variance Genetics Genome-wide association studies Genome-Wide Association Study - methods Genomes Health Health aspects Health risks Hemochromatosis Heterogeneity Humans Hygiene Hypercholesterolemia Infections Instruments (Equipment) Iron Iron (Nutrient) Iron - blood Iron deficiency Iron deficiency anemia Lipids Male Medical research Medical schools Medicine and Health Sciences Mendelian Randomization Analysis - methods Metabolism Middle Aged Minority & ethnic groups Novels Nutrient deficiency Occupational health Phenotype Phenotypes Physiological aspects Population Prospective Studies Proteases Public health Randomization Research centers Restless legs syndrome Risk factors Serine Skin Statistical analysis Transferrin Transferrins University colleges Women |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELXQHiouCMpHF0oxCMEpNImTOOltQVQFqUUCinqz_NkidZNVs3vov2fG9kYbtBI9cF2_rHbnTTxje-aZkLeaM1eaukiq3FZJkesikdayxDbMqkLrpjbYKHx6Vp2cF18vyouNq76wJizIAwfDHabSqFI5ZZlF3RNem9zUynBnvRJKUALNyvViKi61mtTvrqD-WJLlnMemOcazw8jRhwVEGy9AWjM2Ckpeu3-YoSeL667fln7-XUW5EZaOH5IHMZ-ks_A_HpF7tt0lO6fxxPwxcRv272nnKDhM6Fu8vqUm1sJYQ7HbjWJ30aqn0v9KCqkhxQqwbm6P6IzOcbMcN0UohDfTzWMDJ_UCtU_I-fHnn59Okni3QqJrli4T42BdoYzDTllupAY7SFYrvN-PO1PxynItswYAjeOlk6k_X4PcAjgvFMT4p2TSdq3dIzQtjWSlapxpygIIlnlVs0JpzbSUkC9MSbI2rlgECQ3hz9E4LD2ClQSSISIZU_IRGRiwKIDtPwC3ENEtxL_cYkpeIX8idJMOr7GYlU2eVRyysCl54xEogtFilc2lXPW9-PLt1x1AP87uAvo-Ar2PINeBu2gZ2x_AhqjANUK-GyEvg_74NuD-CAgTgx4N76Hvrm3cC5i6_dXyTQ1Prv15-_DrYRi_FOvwWtutEIMrgLzgwOqz4P4DTyzLsZgG-OOjF2NE5Hik_X3lFc0hDYZ1OH_-P5h_Qe5DUovSGhAB9slkebOyLyFxXKoDP0f8AQfzbNw priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELZGkRASQjB-rDDAIARPpkmcxAkvqCCmgrQhAUN9i_yzIK1JWdoH_nvuHKdbUIX2Wn-tKt_5fD7f95mQl1pwl5kiZXlic5YmOmXSWs5sya1KtS4Lg0Th45N8dpp-nmfzPTLruTDYVtnHRB-oTaOxRj4Bv_PvYpfFRCqsAuj15N3qN8P3o_CeNTymcY1cjxNIK8Czxfzi6FVGvtqCemQsToQIJDou4kmw2ZsV7D5ekLTgfLBJeS3_bcQerc6adlc6-m9X5aVt6ugOuR3ySzrtHOIu2bP1PrlxHG7Q98mtrk5HO_rRPeIu2aeljaPgUB2v8ewPNaFXxhqKbDiK7KNNS6X_1xRSR4odYs3SvqVTusRiOhZNKGx_plkGgif1Arb3yenRx-8fZiy8vcB0waM1Mw7OHco4ZNIKIzXMi-SFwvf_hDO5yK3QMi4BUDqRORn5-zfIPcAnUgU5wAMyqpvaHhAaZUbyTJXOlFkKDiCTvOCp0pprKSGfGBPWT3a16iQ2Kn_PJuBo0s1ahcapgnHG5D1aZItFgWz_QXO-qMJ6qyJpVKacstyiXI4oTGIKZYSzXkAnHZNnaM-qY5tul3k1zcokzgVkaWPywiNQJKPGLpyF3LRt9enLjyuAvp1cBfR1AHodQK5B75aBHgFziApdA-SrAXLR6ZPvAh4OgBA49GD4AH25n-O2ulhi8M3ev3cPP98O449in15tmw1i8ISQpAKs-rBbDls78TjBZhuwnxgslIEhhyP1r59e8RzSZDini0f__1uPyU1IZ1FUA2L_IRmtzzf2CaSMa_XUR4O_NQNsSw priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9NAEF_OCuKL-H31Tl1F9ClHmt1kE0Gkiscp9AS1cm9hP6vQJr2mBe-_d2azDRep0NfuLyGdmZ2d3Z35DSGvtGAuNTmPssRmEU80j6S1LLIFs4prXeQGC4Un59nZlH-5SC8OyLZnaxBgs3Nrh_2kpqv5yZ_Lq_cw4d_5rg1itH3oZAnrh6cUzRm7QW4mnHG0-Qnv7hWSIvanLshLFo0SIUIx3f_e0lusPKd_57kHy3nd7ApL_82uvLZcnd4ld0KcScetYdwjB7a6T25Nwk36A-Ku6aWhtaNgSG094_yKmpAjYw3FKjiKVUebhkr_lRRCRoqZYfXCvqVjusBDdDwsobDsmXoRCjupJ659SKann358PItCz4VI5yxeR8bBfkMZhxW0wkgNcpAsV9j3TziTicwKLUcFAAonUidjf-8GMQfYAlew9j8ig6qu7CGhcWokS1XhTJFyULxMspxxpTXTUkIcMSTRVrjlsqXWKP39moAtSSulEpVRBmUMyQfUQIdFYmz_Q72alWGelbE0KlVOWWaRJkfkJjG5MsJZT5zDh-Q56q9sq0y76V2O0yIZZQKisyF56RFIjlFh9s1Mbpqm_Pz15x6g7-f7gL71QG8CyNVgLlqGsgiQITJz9ZCve8hZy0u-C3jcA4LD0L3hQ7TdrYybEly6bzlf5PDk1p53D7_ohvGlmJ9X2XqDGNwZJFyAVh-35t_piY0STLIB_YnexOgpsj9S_f7lmc4hPIb9uXiy7z8_IrchoEVaDfD-x2SwXm3sUwga1-qZ9wN_AWLRbRg priority: 102 providerName: Scholars Portal |
Title | Associations of genetically determined iron status across the phenome: A mendelian randomization study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31220083 https://www.proquest.com/docview/2258795998/abstract/ https://search.proquest.com/docview/2245652476 https://pubmed.ncbi.nlm.nih.gov/PMC6586257 https://doaj.org/article/0adb5bfbe3e645978d2d8bd7fe045644 http://dx.doi.org/10.1371/journal.pmed.1002833 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2IiFeEN8rjGIQgqf0I07iZG_dtGmAWsZgqG-RP8ukNqmW9oH_fneOUy2oDxMvfoh_iSLf-e5s3_1MyEfFmY11GgVJaJIgClUUCGNYYDJmZKRUlmosFJ5Mk_Or6Ossnu2RuKmFcUn7Sl73i8WyX1z_cbmVq6UaNHlig4vJCXhNCNv5YJ_sc8aaJbpfZWVDt7GC1GPBKOTc18sxPhp48fRX4Ggc92jK8B4dNgoxC4C1XJNj8N_a6c5qUVa7gtB_cynvOKezJ-SxjyrpuP77p2TPFM_Iw4k_N39O7B0pVLS0FNSmrl5c_KXaZ8QYTbHmjWKN0aaiwv0lhQCRYh5YuTRHdEyXuGWOWyMUnJwul76Mkzqa2hfk6uz018l54G9YCFTKhutAW1hdSG2xXpZroWBIBEsl3vLHrU54YrgSowwAmeWxFUN3ygYRBkg-kuDpX5JOURbmgNBhrAWLZWZ1FkcgZhEmKYukUkwJAVFDlwTN4Oarmkgjd6dpHBYg9SjlKJfcy6VLjlECWyzSYLsH5c0898qQD4WWsbTSMIOkODzVoU6l5tY4mpyoS96h_PK6pnQ7mfNxnIWjhEMs1iUfHAKpMArMtZmLTVXlX77_vgfo5_Q-oMsW6LMH2RLURQlfBAFjiDxcLeSnFnJes5DvAh62gGAeVKv7AHW3GeMqBwPuLpjPUniz0efd3e-33fhRzMYrTLlBDK4DwoiDVF_V6r-VUzOZuoS3JkZLkO0emOaO19xP69f__eYb8gjiWWTVAON_SDrrm415CzHjWvbAUsx4jzw4Pp1eXPbczgu0336k0E4ibMGG3AKnn3Gv |
link.rule.ids | 230,315,733,786,790,870,891,2115,2236,12083,21416,24346,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829,74102,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegkwAJIRgfKwxmEIKnsDZO4oQX1KFNHawFjQ3tzfJnQVqTsrQP_PfcOW5Y0IT2Gv8SRb7z-e589zMhrzVnLjV5EmWxzaIk1kkkrWWRLZhVidZFbrBReDLNxqfJp7P0LCTc6lBWubaJ3lCbSmOOfBf0zt-LXeQfFr8ivDUKT1fDFRo3yUbCIFTpkY29_enX4zbkKgY-y4I8ZNEw5jw0zzE-3A2yereAXccTkeaMdTYnz-HfWure4ryqr3JD_62mvLQ9Hdwn94JfSUeNIjwgN2y5SW5Nwsn5Jrnb5Odo03b0kLhLcqlp5SgoUtPPeP6bmlAjYw3FLjiKXUermkr_1xRcRoqVYdXcvqcjOsckOiZLKGx7ppqHxk7qiWsfkdOD_ZOP4yjcuRDpnA2WkXEQbyjjsIOWG6lhXiTLFd77x53JeGa5lsMCAIXjqZMDf-4GPgfoQqJg739MemVV2i1CB6mRLFWFM0WagOBlnOUsUVozLSX4EX0SrSdbLBpqDeHP1ziEJM2sCRSOCMLpkz2USItFYmz_oLqYibDOxEAalSqnLLNIk8NzE5tcGe6sJ85J-mQH5SmaLtN2eYtRWsTDjIN31ievPALJMUqsvpnJVV2Lwy_frwH6Nr0O6LgDehtArgL10TK0RcAcIjNXB_mmg5w1vORXAbc7QDAYujO8hbq8nuNa_F1a8OZav68eftkO40exPq-01QoxGBnECQepPmmWQysnNoyxyAbkxzsLpSPI7kj584dnOgf3GOJz_vT_v7VDbo9PJkfi6HD6-Rm5Ay4tEmuA_d8mveXFyj4Ht3GpXgTb8AeG-Wzk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegSBMSQjA-VhjMIARPoWmcxAkvqHxUG7CCgKG-Wf4sSGtSlvaB_547x-0WVKG9xr9Eke98d7bvfkfIM82Zy0yRRnli8yhNdBpJa1lkS2ZVqnVZGCwUPp7khyfph2k2DflPTUirXNtEb6hNrfGMfAB65_til8XAhbSIL-_Grxe_I-wghTetoZ3GVXINvGSM3Qz49HzzVcb-vAUZyaJhwnkoo2N8OAhSe7kA_-MpSQvGOm7Ks_lvbHZvcVo32wLSf_MqLziq8S1yM0SYdNSqxG1yxVa7ZOc43KHvkhvtSR1tC5DuEHdBQg2tHQWVaisbT_9QE7JlrKFYD0ex_mjVUOn_mkLwSDFHrJ7bV3RE53icjscmFBygqeehxJN6Ctu75GT8_vvbwyh0X4h0weJlZBzsPJRxWEvLjdQwL5IVCjsAcmdynluu5bAEQOl45mTsb-Ag-gCtSBVEAfdIr6oru0donBnJMlU6U2YpqIBM8oKlSmumpYSIok-i9WSLRUuyIfxNG4fNSTtrAoUjgnD65A1KZINFimz_oD6bibDiRCyNypRTllkkzOGFSUyhDHfWU-ikfXKA8hRtvelmoYtRVibDnEOc1idPPQJpMipUuJlcNY04-vzjEqBvk8uAvnZALwLI1aA-WoYCCZhD5OjqIJ93kLOWoXwbcL8DBNOhO8N7qMvrOW7E-SKDN9f6vX34yWYYP4qZepWtV4jBPUKScpDq_XY5bOTEhgmm24D8eGehdATZHal-_fSc5xAow06dP_j_bx2QHTAK4tPR5ONDch1iW2TYAEewT3rLs5V9BPHjUj32huEvq59vqg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Associations+of+genetically+determined+iron+status+across+the+phenome%3A+A+mendelian+randomization+study&rft.jtitle=PLoS+medicine&rft.au=Gill%2C+Dipender&rft.au=Benyamin%2C+Beben&rft.au=Moore%2C+Luke+S.+P&rft.au=Monori%2C+Grace&rft.date=2019-06-20&rft.pub=Public+Library+of+Science&rft.issn=1549-1277&rft.eissn=1549-1676&rft.volume=16&rft.issue=6&rft_id=info:doi/10.1371%2Fjournal.pmed.1002833&rft.externalDocID=A592167397 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-1676&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-1676&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-1676&client=summon |